Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 18, 2022

View Archived Issues

Novel cdkl5-mutated zebrafish model of CDKL5 deficiency disorder

Insulin is tissue-specific, with link to weight complex

Purdue Research Foundation patents protein kinase inhibitors

Universite de Franche-Comte presents compounds targeting histamine H3 receptors

TCR-modified T cells targeting TdT show antileukemia promise in vivo

SCN5A tied to drug-induced cardiac arrythmia

PEGylated circularly permuted capsule depolymerase enzyme protects mice from anthrax infection

VelociT mouse model for analyzing T-cell function in human disease

Ono and Neurimmune expand drug discovery collaboration for neurodegenerative diseases

EZH2 as a promising therapeutic target for prostate cancer

MCC-1381, a pan-HDAC inhibitor with promising anticancer activity

ZIP8 found to correlate with severe rheumatoid arthritis

4basebio and eTheRNA collaborate to evaluate linear DNA for mRNA production

Avacta selects FAP-targeted proteasome inhibitor for preclinical development

SUW-133 diminishes HIV viral load in vivo

Researchers suggest ZEB2 targeting as an approach for atherosclerosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.